No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects.
Purpose: Rosuvastatin disposition is modulated by the expression and activity of several membrane transporters including BCRP (ABCG2). The objective of our study was to investigate the effects of pantoprazole, a previously proposed BCRP inhibitor, on the disposition of rosuvastatin. Methods: The imp...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 72; no. 8; pp. 925 - 932 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | clinical trial equations & formulas research tables/charts Journal Article |
| Publicado: |
Springer Nature
Aug2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |